Advertisement
Stereotaxis, Inc.

Stereotaxis, Inc. (STXS) Stock Overview

Explore Stereotaxis, Inc.’s financial performance, market position, analyst ratings, and future outlook.

STXSAMEX
HealthcareMedical - Equipment & Services
$1.70
$0.04(2.30%)
U.S. Market opens in NaNh NaNm
Advertisement

Stereotaxis, Inc. (STXS)

Meyka AI Score

Z

Key Financials

Market Cap165.7M
P/E Ratio-6.90
EPS (TTM)$-0.17
ROE-1.53%
Fundamental Analysis

AI Price Forecasts

1 Month$1.81
3 Months$2.12
1 Year Target$2.58

STXS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Stereotaxis, Inc. (STXS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 42.92, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.58.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.90 and a market capitalization of 165.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.59%
5-Day Change
-5.31%
1-Month Change
-6.35%
3-Month Change
-9.36%
6-Month Change
-32.47%
Year-to-Date (YTD) Change
-26.30%
1-Year Change
-24.33%
3-Year Change
14.53%
5-Year Change
-82.83%
All-Time (Max) Change
-97.62%

Contact Information

314 678 6100
710 North Tucker Boulevard, St. Louis, MO, 63101

Company Facts

1,350 Employees
IPO DateAug 12, 2004
CountryUS
Actively Trading

Frequently Asked Questions